BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2836600)

  • 1. Second malignant neoplasms in survivors of Wilms' tumor: a report from the National Wilms' Tumor Study.
    Breslow NE; Norkool PA; Olshan A; Evans A; D'Angio GJ
    J Natl Cancer Inst; 1988 Jun; 80(8):592-5. PubMed ID: 2836600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second malignant neoplasms following treatment for Wilm's tumor: a report from the National Wilms' Tumor Study Group.
    Breslow NE; Takashima JR; Whitton JA; Moksness J; D'Angio GJ; Green DM
    J Clin Oncol; 1995 Aug; 13(8):1851-9. PubMed ID: 7636528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second malignant neoplasms among children, adolescents and young adults with Wilms tumor.
    Lee JS; Padilla B; DuBois SG; Oates A; Boscardin J; Goldsby RE
    Pediatr Blood Cancer; 2015 Jul; 62(7):1259-64. PubMed ID: 25809878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second neoplasms after Wilms' tumor in childhood.
    Li FP; Yan JC; Sallan S; Cassady JR; Danahy J; Fine W; Gelber RD; Green DM
    J Natl Cancer Inst; 1983 Dec; 71(6):1205-9. PubMed ID: 6317934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metachronous bilateral Wilms' tumor, National Wilms' Tumor Study.
    Jones B; Hrabovsky E; Kiviat N; Breslow N
    Am J Clin Oncol; 1982 Oct; 5(5):545-50. PubMed ID: 6295133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant neoplasms after treatment for metachronous bilateral Wilms' tumor: a literature review.
    Paulino AC
    Pediatr Hematol Oncol; 1999; 16(6):533-8. PubMed ID: 10599093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma as second malignant neoplasms in successfully treated Wilms' tumor patients. A National Wilms' Tumor Study report.
    Kovalic JJ; Thomas PR; Beckwith JB; Feusner JH; Norkool PA
    Cancer; 1991 Jan; 67(2):342-4. PubMed ID: 1845942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metachronous bilateral Wilms' tumor: the importance of time interval to the development of a second tumor.
    Paulino AC; Thakkar B; Henderson WG
    Cancer; 1998 Jan; 82(2):415-20. PubMed ID: 9445201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second primary neoplasms in survivors of Wilms' tumour--a population-based cohort study from the British Childhood Cancer Survivor Study.
    Taylor AJ; Winter DL; Pritchard-Jones K; Stiller CA; Frobisher C; Lancashire ER; Reulen RC; Hawkins MM;
    Int J Cancer; 2008 May; 122(9):2085-93. PubMed ID: 18196579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extraskeletal osteogenic sarcoma after treatment for Wilms' tumor.
    Belasco JB; Meadows AT; Chatten J; Borden S; Schnaufer L
    Cancer; 1982 Nov; 50(9):1894-8. PubMed ID: 6288228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer in female survivors of Wilms tumor: a report from the national Wilms tumor late effects study.
    Lange JM; Takashima JR; Peterson SM; Kalapurakal JA; Green DM; Breslow NE
    Cancer; 2014 Dec; 120(23):3722-30. PubMed ID: 25348097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wilms' tumor at the Children's Hospital of Eastern Ontario: 1990-2001.
    Pianezza ML; Rubin S; Bass J; Chou S; Pike JG; Leonard MP
    Can J Urol; 2004 Feb; 11(1):2151-6. PubMed ID: 15003157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary leukemia following successful treatment of Wilms' tumor.
    Moss TJ; Strauss LC; Das L; Feig SA
    Am J Pediatr Hematol Oncol; 1989; 11(2):158-61. PubMed ID: 2546463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
    Dome JS; Cotton CA; Perlman EJ; Breslow NE; Kalapurakal JA; Ritchey ML; Grundy PE; Malogolowkin M; Beckwith JB; Shamberger RC; Haase GM; Coppes MJ; Coccia P; Kletzel M; Weetman RM; Donaldson M; Macklis RM; Green DM
    J Clin Oncol; 2006 May; 24(15):2352-8. PubMed ID: 16710034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaplastic Wilms' tumor: clinical and pathologic studies.
    Bonadio JF; Storer B; Norkool P; Farewell VT; Beckwith JB; D'Angio GJ
    J Clin Oncol; 1985 Apr; 3(4):513-20. PubMed ID: 2984344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and outcomes of patients with late recurrence of Wilms' tumor.
    Malogolowkin M; Spreafico F; Dome JS; van Tinteren H; Pritchard-Jones K; van den Heuvel-Eibrink MM; Bergeron C; de Kraker J; Graf N;
    Pediatr Blood Cancer; 2013 Oct; 60(10):1612-5. PubMed ID: 23737480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second malignant neoplasms in patients treated on SIOP Wilms tumour studies and trials 1, 2, 5, and 6.
    Carli M; Frascella E; Tournade MF; de Kraker J; Rey A; Guzzinati S; Burgers JM; Delemarre JF; Masiero L; Simonato L
    Med Pediatr Oncol; 1997 Oct; 29(4):239-44. PubMed ID: 9251727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congestive heart failure after treatment for Wilms' tumor: a report from the National Wilms' Tumor Study group.
    Green DM; Grigoriev YA; Nan B; Takashima JR; Norkool PA; D'Angio GJ; Breslow NE
    J Clin Oncol; 2001 Apr; 19(7):1926-34. PubMed ID: 11283124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac function in Wilms' tumor survivors.
    Sorensen K; Levitt G; Sebag-Montefiore D; Bull C; Sullivan I
    J Clin Oncol; 1995 Jul; 13(7):1546-56. PubMed ID: 7602343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diastolic hypertension in Wilms' tumor survivors: a late effect of treatment? A report from the National Wilms' Tumor Study Group.
    Finklestein JZ; Norkool P; Green DM; Breslow N; D'Angio GJ
    Am J Clin Oncol; 1993 Jun; 16(3):201-5. PubMed ID: 8393271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.